APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneOperatingExpenses01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:FourOperatingExpenses01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentRevenue01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentRevenue02Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentRevenue03Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:FourReportableSegmentRevenue01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:FourReportableSegmentRevenue02Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:FourReportableSegmentRevenue03Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentResults01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentResults02Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentResults03Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:FourReportableSegmentResults01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:FourReportableSegmentResults02Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:FourReportableSegmentResults03Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentAssets01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentAssets02Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentAssets03Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2020-09-30in-bse-fin:OneReportableSegmentLiabilities01Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2020-09-30in-bse-fin:OneReportableSegmentLiabilities02Member APOLLOHOSP2020-07-012020-09-30in-bse-fin:OneReportableSegmentLiabilities03Member APOLLOHOSP2020-09-30in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares APOLLOHOSP 2020-04-01 2021-03-31 2020-11-02 INR Lakhs Half yearly true Cash Flow Indirect Multi segment 2020-07-01 2020-09-30 Unaudited Standalone 24144500000.00 47900000.00 24192400000.00 3607500000.00 10512000000.00 145900000.00 3363800000.00 971500000.00 1163300000.00 4033100000.00 23797100000.00 395300000.00 -10900000.00 384400000.00 -189700000.00 248900000.00 59200000.00 0.00 325200000.00 0.00 0.00 0.00 325200000.00 -42800000.00 282400000.00 325200000.00 695600000.00 5 2.34 2.34 0.00 0.00 2.34 2.34 0.83 0.77 2.53 Current tax and Deferred Tax expense for three and six months ended September 30, 2020 includes tax of prior year amounting to Rs.1,550 lakhs1.¿¿¿ The unaudited standalone financial results of Apollo Hospitals Enterprise Limited (¿the Company¿) for the three and six months ended September 30, 2020 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on November 10, 2020 and November 11, 2020, respectively and have been subjected to limited review by the statutory auditors.¿2.¿¿¿ The Board of Directors, in their meeting held on November 11, 2020 have approved the proposal for executing¿ a definitive Share Purchase Agreement (SPA) for the acquisition of 50% equity stake held by Gleneagles Development PTE Limited, Singapore, in Apollo Gleneagles Hospital Limited, Kolkata (¿AGHL¿), a joint venture in which the Company holds a 50% equity stake, for a cash¿ consideration of Rs 41,000 lakhs. Pending execution of the said SPA and completion of the other allied conditions, no effect of the acquisition has been given in these financial results.¿3.¿¿¿ The Board of Directors have approved the proposal to raise funds by way of¿ issue of securities through preferential allotment and / or Qualified Institutional Placement (QIP) or any equivalent capital raising method permitted by applicable laws, subject to approval of the shareholders , up to a maximum aggregate limit of Rs. 150,000 lakhs.4.¿¿¿ The listed non-convertible debentures of the Company aggregating to Rs. 50,000 lakhs as on September 30, 2020 are secured by way of first charge on the Company's properties and the asset cover thereof exceeds hundred percent of the principal amount of the said debentures.5.¿¿¿ The Company¿s debt instruments were assigned a rating of AA/Stable by CRISIL indicating high degree of safety.¿om).¿ Multi segment 2020-04-01 2020-09-30 Unaudited Standalone 43759600000.00 64800000.00 43824400000.00 5967400000.00 21189400000.00 -1188600000.00 7131600000.00 1997600000.00 2427700000.00 7763200000.00 45288300000.00 -1463900000.00 -10900000.00 -1474800000.00 -116100000.00 -192800000.00 -308900000.00 0.00 -1165900000.00 0.00 0.00 0.00 -1165900000.00 -58900000.00 -1224800000.00 695600000.00 5 -8.38 -8.38 0.00 0.00 -8.38 -8.38 0.83 0.77 2.53 6.¿The Scheme of Arrangement for transfer of front-end retail pharmacy business included in the standalone pharmacy segment (¿divestment business¿) to Apollo Pharmacies Limited (¿APL¿) , a wholly owned subsidiary of Apollo Medicals Private Limited (¿AMPL¿) for an overall cash consideration of Rs.52,780 lakhs was approved by the National Company Law Tribunal vide their Order dated August 3, 2020. The Scheme was effective from September 1, 2020.As per the Scheme, accounting in the books of the Company is given effect as on the effective date considering the transfer of the divestment business with effect from April 1, 2019. Consequently, the net economic benefit transferred from the appointed date till the effective date related to divestment business of Rs. 8,560 lakhs has been included under exceptional items.Pursuant to the Scheme becoming effective, the Company invested Rs.3,650 lakhs and its ownership interest in AMPL changed to 25.50%, resulting in loss of control with effect from September 1, 2020. Net gain on disposal of divestment business of Rs. 8,450 lakhs has been included under exceptional items.Retail Pharmacy segment as presented in these standalone financial results includes transactions of the divestment business till the effective date. Post the disposal of divestment business, the Company has identified Pharmacy distribution as a new segment with effect from September 1, 2020. The Company henceforth has Healthcare and Pharmacy Distribution as its operating and reportable segments. Healthcare segment represents hospitals and hospital based pharmacies. Pharmacy distribution segment represents the business of procurement and distribution of pharmaceutical, Fast Moving Consumer Goods (FMCG) and private label products.The figures for the three and six months ended September 30, 2020 are not comparable with the figures for the previous three months ended June 30, 2020, corresponding three months and six months ended September 30, 2019¿¿ Other Expenses 4033100000.00 Other Expenses 7763200000.00 Healthcare services 10626400000.00 Pharmacy Distribution 3611800000.00 Retail Pharmacy 9907000000.00 Healthcare services 17450600000.00 Pharmacy Distribution 3611800000.00 Retail Pharmacy 22698400000.00 700000.00 1200000.00 24144500000.00 43759600000.00 Healthcare services 450000000.00 Pharmacy Distribution 195800000.00 Retail Pharmacy 673000000.00 Healthcare services -1219500000.00 Pharmacy Distribution 195800000.00 Retail Pharmacy 1492600000.00 971500000.00 1997600000.00 -37100000.00 -53900000.00 384400000.00 -1474800000.00 Healthcare Services 69524300000.00 Pharmacy Distribution 0.00 Retail Pharmacy 7456500000.00 14204700000.00 Healthcare services 15837800000.00 Pharmacy Distribution 0.00 Retail Pharmacy 2745100000.00 34324800000.00 0.00 -1001800000.00 -2637000000.00 0.00 -354300000.00 48500000.00 3400000.00 826900000.00 0.00 186200000.00 0.00 178900000.00 0.00 2427700000.00 0.00 0.00 270500000.00 1367900000.00 -1230100000.00 0.00 0.00 51700000.00 0.00 -3300000.00 0.00 0.00 0.00 733100000.00 0.00 764900000.00 -709900000.00 0.00 -1997600000.00 0.00 486100000.00 0.00 801600000.00 5278000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1451000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 87500000.00 31500000.00 0.00 0.00 0.00 0.00 48700000.00 0.00 -388600000.00 0.00 3368100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4003800000.00 4152100000.00 475000000.00 0.00 382600000.00 1745000000.00 0.00 -165000000.00 -2915900000.00 1253800000.00 0.00 1253800000.00 2804600000.00 4058400000.00